SCHEMBL14953740

SCHEMBL14953740

O=Cc1cc(C(=O)O)cc(C=O)c1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 1/20 0.49
▸ KDM4E B2RXH2 2/20 0.44
▸ POLB P06746 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ HTT P42858 1/20 0.44
▸ CASP6 P55212 1/20 0.44
▸ CTDSP1 Q9GZU7 1/20 0.44
▸ ERN1 O75460 4/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ CA12 O43570 2/20 0.42
▸ CA1 P00915 2/20 0.42
▸ CA2 P00918 2/20 0.42
▸ CA7 P43166 2/20 0.42
▸ CA9 Q16790 2/20 0.42
▸ CA14 Q9ULX7 2/20 0.42
▸ UNG P13051 1/20 0.42
▸ TPMT P51580 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ TP53 P04637 2/20 0.41
▸ LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21938918 0.81 CYP19A1 (0.37) CYP19A1KDM4EPOLBL3MBTL1HTT
SCHEMBL12491809 0.81 ERN1 (0.54) CYP19A1KDM4EPOLBL3MBTL1HTT
SCHEMBL21938917 0.79 CDK4 (0.38) CYP19A1KDM4EPOLBL3MBTL1HTT
SCHEMBL7669530 0.76 MAPT (0.64) CYP19A1KDM4EPOLBL3MBTL1ERN1
SCHEMBL4918747 0.74 ALDH1A1 (0.52) KDM4EPOLBL3MBTL1CTDSP1ERN1
SCHEMBL29941258 0.74 ALDH1A1 (0.52) KDM4EPOLBL3MBTL1CTDSP1ERN1
SCHEMBL29266725 0.73 CYP3A4 (0.35) CYP19A1KDM4EPOLBL3MBTL1HTT
SCHEMBL25385602 0.73 TTR (0.67) KDM4EPOLBL3MBTL1ERN1ALDH1A1
SCHEMBL22400345 0.73 TTR (0.50) CYP19A1KDM4EPOLBL3MBTL1HTT
SCHEMBL5648278 0.73 ERN1 (0.50) CYP19A1KDM4EPOLBL3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130121919-A1 HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2013-05-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130121919-A1 HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF EP300, KAT2A, NAA40 CYP19A1 4556/4885KDM4E 1505/4885POLB 2276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback